Scleritis After COVID-19 Vaccine Booster
Author Information
Author(s): Kimia Jazi, Mahnaz Rahimi, Fatemeh Hasani, Maryam Shirmohammadi, Maryam Masoumi
Primary Institution: Qom University of Medical Sciences, Qom, Iran
Hypothesis
Can the Sinopharm COVID-19 vaccine trigger autoimmune reactions such as scleritis?
Conclusion
The patient's scleritis completely resolved after treatment with corticosteroids and immunosuppressants following the booster dose of the Sinopharm COVID-19 vaccine.
Supporting Evidence
- The patient had no previous adverse reactions to earlier doses of the vaccine.
- Laboratory tests ruled out other causes of scleritis.
- The condition resolved completely after treatment.
Takeaway
A woman developed eye inflammation after her COVID-19 vaccine booster, but doctors helped her get better with medicine.
Methodology
The patient was treated with tapering doses of prednisolone and azathioprine over a two-week period.
Limitations
The study did not evaluate ocular symptoms with MRI and had a follow-up period of only one year.
Participant Demographics
52-year-old female patient with no significant past medical history.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website